Source: Annual Congress 2008 - Improved diagnosis and clinical decision-making by integrating information from new biomarkers
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
B. Mueller (Basel, Switzerland). Procalcitonin to complement microbiology in LRTI and other infections. Annual Congress 2008 - Improved diagnosis and clinical decision-making by integrating information from new biomarkers

Member's Comments

No comment yet.

Related content which might interest you: Procalcitonin (PCT) as a diagnostic tool in lower respiratory tract infections (LRTI) and TB Source: Eur Respir J 2001; 18: Suppl. 33, 542s Year: 2001 Procalcitonin has wider applicability in community-acquired pneumonia than other biomarkers Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018 Urinary antigen of S. pneumoniae in the microbiological diagnosis of lower respiratory tract infections Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Serum procalcitonin and community-acquired pneumonia in childhood Source: Eur Respir J 2005; 26: Suppl. 49, 167s Year: 2005 Procalcitonin as a diagnostic tool in systemic bacterial sepsis Source: Annual Congress 2009 - Severe sepsis and multiple organ failure Year: 2009 Impact of appropriate diagnostics on the management of respiratory tract infections Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021 Year: 2021 Potential impact and relevance of diagnostics in the management of respiratory tract infections: from COVID to hospital-acquired pneumonia Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021 Assessment of urinary pneumococcal antigen for etiological diagnosis of community-acquired pneumonia Source: Annual Congress 2003 - New aspects of community acquired pneumonia Year: 2003 BAL and microbiological surveillance of nosocomial pneumonia in ARDS patients Source: Eur Respir J 2006; 28: Suppl. 50, 786s Year: 2006 Procalcitonin as etiological marker of severe community-acquired pneumonia Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection Source: Eur Respir J 2010; 36: 601-607 Year: 2010 The role of Procalcitonin in management of pleural infections Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019 Usefullness of CPR and PCT in the etiological diagnosis of community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults Source: Eur Respir J 2003; 21: 209-214 Year: 2003 Role of pneumococcus urinary antigen testing in the clinical presentation and outcome of pneumococcal bacteraemic community acquired pneumonia Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011 Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Virological diagnosis in community-acquired pneumonia in immunocompromised patients Source: Eur Respir J 2008; 31: 618-624 Year: 2008 Sputum and streptococcus pneumoniae urinary antigen test for diagnosis of pneumococcal community acquired pneumonia Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008